
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
Filed with NSE · · 2 pages · English

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream USP, 0.05%.".
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals